S. Pabst

发表

A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1.

C. Gieger, H. Wichmann, S. Schreiber, 2012, American journal of respiratory and critical care medicine.

FKBP12+ S100+ Dendritic Cells as Novel Cellular Targets for Rapamycin in Post Stent Neointima

M. Peuster, G. Nickenig, D. Skowasch, 2011 .

BTNL2 gene variant and sarcoidosis

A. Gillissen, B. Wollnik, C. Grohé, 2006, Thorax.

Apparent response to anti-IgE therapy in two patients with refractory “forme fruste” of Churg–Strauss syndrome

C. Grohé, V. Tiyerili, S. Pabst, 2008, Thorax.

Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011.

S. Ley, S. Sorichter, G. Riemekasten, 2011, International journal of cardiology.

[Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010].

S. Ley, S. Sorichter, G. Riemekasten, 2010, Deutsche medizinische Wochenschrift.

A stop codon polymorphism of toll-like receptor 5 is associated with a stable course of chronic obstructive lung disease

A. Gillissen, C. Grohé, P. Knuefermann, 2006, European Respiratory Review.

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

C. Sinning, A. Hager, S. Sorichter, 2018, International journal of cardiology.

A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomaldominant inherited congenital heart disease

B. Wollnik, C. Grohé, H. Vetter, 2007, Clinical Research in Cardiology.

Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study

T. Greulich, A. Gillissen, J. Ritz, 2021, ERJ Open Research.

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation.

B. Seliger, A. Schmidt, C. Grohé, 2011, Clinical immunology.

Sarkoidose

D. Skowasch, C. Grohé, S. Pabst, 2012 .

Obstructive sleep apnoea as a risk factor for atherosclerosis – implication for preventive and personalised treatment

G. Nickenig, D. Skowasch, S. Pabst, 2011, EPMA Journal.

Clinical experience with the implantable cardioverter defibrillator.

D. T. Rock, H. Deantonio, W. R. Chitwood, 1994, The Annals of thoracic surgery.

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

C. Grohé, P. Velling, D. Skowasch, 2011, European journal of medical research.

First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis

Yun Li, B. Wollnik, C. Grohé, 2010, Thorax.

Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease

A. Gillissen, C. Grohé, S. Pabst, 2009, Therapeutic advances in respiratory disease.

ADAM33 G ENE POLYMORPHISMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

G. Nickenig, C. Touron, D. Skowasch, 2009 .

[Non-small-cell lung carcinoma].

S. Stier, C. Grohé, H. Vetter, 2004, Praxis.

Pulmonary hypertension in HIV infection: a prospective echocardiographic study

J. Rockstroh, G. Nickenig, C. Boesecke, 2015, HIV medicine.

Toll-Like Receptor 2 Gene Polymorphisms Arg677Trp and Arg753Gln in Chronic Obstructive Pulmonary Disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, Lung.

COPD_A_195852 1441..1453

R. Buhl, A. Kondla, K. Steinmetz, 2019 .

Cardiac Sarcoidosis : Diagnostic and Therapeutic Algorithms

C. Tschöpe, S. Störk, C. Grohé, 2014 .

Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience.

G. Nickenig, C. Grohé, D. Skowasch, 2013, Advances in experimental medicine and biology.

Pulmonary aspergillosis: therapeutic management and prognostic factors from 16 years of monocenter experience.

D. Skowasch, S. Pabst, M. Krüger, 2013, Advances in experimental medicine and biology.

[Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].

G. Nickenig, D. Skowasch, C. Hammerstingl, 2010, Pharmazie in unserer Zeit.

Antiplatelet effects of n-3 polyunsaturated fatty acids compared with aspirin: a pilot study with whole-blood aggregometry.

G. Nickenig, D. Skowasch, R. Andrié, 2009, Thrombosis research.

[Acute coronary syndrome as a first manifestation of Churg-Strauss syndrome].

G. Nickenig, D. Skowasch, V. Tiyerili, 2012, Deutsche medizinische Wochenschrift.

Non-invasive diagnosis of pulmonary hypertension

S. Ley, S. Sorichter, G. Riemekasten, 2010 .

Apoptosis-regulated survival of primarily extravascular cells in proliferative active poststent neointima.

M. Peuster, G. Nickenig, U. Welsch, 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Exogen allergische Alveolitis

H. Vetter, C. Grohé, B. Weisser, 2004 .

Akutes Koronarsyndrom als kardiale Manifestation einer Granulomatose mit Polyangiitis

G. Nickenig, D. Skowasch, V. Tiyerili, 2013, Deutsche Medizinische Wochenschrift.

Phenotypes of organ involvement in sarcoidosis

J. Milanowski, A. Günther, M. Krawczak, 2018, European Respiratory Journal.

Caspase recruitment domain 15 gene haplotypes in sarcoidosis.

S. Cichon, M. Nöthen, T. Wienker, 2011, Tissue antigens.

VEGF gene haplotypes are associated with sarcoidosis.

S. Cichon, M. Nöthen, T. Wienker, 2010, Chest.

ADAM33 gene polymorphisms in chronic obstructive pulmonary disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, European journal of medical research.

Transforming growth factor-&bgr; gene polymorphisms in different phenotypes of sarcoidosis

G. Nickenig, S. Stier, C. Grohé, 2010, European Respiratory Journal.

Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.

C. Gieger, M. Nöthen, K. Strauch, 2015, American journal of respiratory and critical care medicine.

Toll‐like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis

A. Gillissen, C. Grohé, G. Baumgarten, 2006, Clinical and experimental immunology.

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, European journal of medical research.

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting

R. Buhl, A. Kondla, K. Steinmetz, 2019, International journal of chronic obstructive pulmonary disease.

Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population.

R. Fimmers, H. Schild, A. Goebel, 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis.

G. Nickenig, A. Ghanem, D. Skowasch, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation

L. Lickfett, G. Nickenig, D. Skowasch, 2010, Journal of Interventional Cardiac Electrophysiology.

Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study

G. Nickenig, C. Grohé, D. Skowasch, 2012, PloS one.

Impact of Untreated Obstructive Sleep Apnea on Left and Right Ventricular Myocardial Function and Effects of CPAP Therapy

G. Nickenig, M. Wiesen, D. Skowasch, 2013, PloS one.

Effects of untreated obstructive sleep apnea on left and right ventricular myocardial function.

G. Nickenig, M. Wiesen, D. Skowasch, 2012, International journal of cardiology.

Diagnostic Value of Echocardiography in the Diagnosis of Pulmonary Hypertension

G. Nickenig, D. Skowasch, R. Schueler, 2012, PloS one.

[Extrinsic allergic alveolitis].

C. Grohé, H. Vetter, B. Weisser, 2004, Praxis.

Toll-like receptor-9 polymorphisms in sarcoidosis and chronic obstructive pulmonary disease.

Georg Nickenig, A. Gillissen, G. Nickenig, 2013, Advances in experimental medicine and biology.

High prevalence of peripheral arterial occlusive disease (PAOD) in patients with obstructive sleep apnea

G. Nickenig, D. Skowasch, C. Hammerstingl, 2012 .

[Diabetes insipidus due to neurosarcoidosis].

C. Grohé, D. Skowasch, S. Pabst, 2011, Pneumologie.

[Clinical classification and initial diagnosis of pulmonary hypertension: recommendations of the Cologne Consensus Conference 2016].

C. Sinning, A. Hager, S. Sorichter, 2016, Deutsche medizinische Wochenschrift.

A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1

C. Gieger, H. Wichmann, P. Rosenstiel, 2012 .

Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis

P. Rosenstiel, A. Franke, M. Nothnagel, 2012, European Respiratory Journal.

Prevalence of sarcoidosis-associated pulmonary hypertension: cumulative analysis of two PULSAR studies

C. Grohé, D. Skowasch, S. Pabst, 2020, European Respiratory Journal.

Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer: The APRONTA Trial

C. Schumann, N. Dickgreber, W. Schuette, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ADAM 33 GENE POLYMORPHISMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

A. Gillissen, G. Nickenig, C. Grohé, 2022 .